1.
Preclinical efficacy and cellular mechanisms of a polyherbal formulation in doxorubicin nephrotoxicity: PRECLINICAL SAFETY AND EFFICACY OF A POLYHERBAL FORMULATION. IJTK. 2025;24(1):33-41. doi:10.56042/ijtk.v24i1.5664